IDT Australia Limited (ASX: IDT)
Health Care · Pharmaceuticals · AU
AU$0.04
-7.32% today · -41.5% 1Y
IDT Australia Limited (ASX: IDT) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $11.33M and employs 156 people.
Over the last twelve months the share price has lost 41.5%, trading between 0.03 and 0.07.
Tweenvest scores IDT Australia Limited across four factors: quality 50/100, value 85/100, growth 65/100. Its strongest factor is value.
IDT price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $11.33M
- Revenue (TTM)
- $14.10M
- P/E
- —
- EPS
- -0.01
- Dividend yield
- —
- Beta (5Y)
- 0.93
- 52-week high
- AU$0.07
- 52-week low
- AU$0.03
- Avg volume (3M)
- —
- Shares outstanding
- 427.26M
- Employees
- 156
- Next earnings
- —
About IDT Australia Limited
IDT Australia Limited is an enterprise deeply involved in the entire lifecycle of pharmaceutical products, from initial research and development through to manufacturing and global distribution of both active pharmaceutical ingredients (APIs) and finished dosage forms. The company furnishes comprehensive analytical support, including the establishment of testing methodologies, stability assessments utilizing specialized chambers, and quality control laboratory services for both chemical and microbiological applications. Furthermore, its service offerings span project management, chemical processing, advanced analytical chemistry, pharmacy support, clinical trial packaging, and regulatory compliance assistance, alongside pharmaceutical development expertise across diverse dosage forms. Notably, IDT Australia also provides medicinal cannabis products and a broad array of contract manufacturing solutions. Established in 1975, the firm is headquartered in Boronia, Australia.
- ISIN
- AU000000IDT0
- Founded
- 1975
- Listed since
- Apr 1, 1988
- Exchange
- Australian Securities Exchange
- Currency
- AUD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Argenica Therapeutics LimitedASX: AGN | $11.65M | AU$0.13 | -13.33% |
| Aspire-Lakewood Holdings, Inc.NasdaqCM: ASBP | $11.64M | $7.64 | -7.95% |
| OncoZenge AB (publ)OM: ONCOZ | $11.54M | Skr3.79 | -9.33% |
| Silva Pharmaceuticals LimitedDSE: SILVAPHL | $11.53M | Tk10.40 | -16.80% |
| Together Pharma LtdTASE: TGTR | $11.32M | ₪2.00 | -3.71% |
| Pharmaids Pharmaceuticals LimitedBSE: 524572 | $11.23M | Rs30.81 | +2.19% |
| Avicanna Inc.TSX: AVCN | $11.10M | CA$0.12 | +15.00% |
| Makers Laboratories LimitedBSE: 506919 | $11.07M | Rs181.60 | -0.06% |
Figures last refreshed Oct 11, 2026.